Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.085,18
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aileron Therapeutics Inc (ALRN) Aileron Therapeutics Inc (ALRN) Notizie

Aileron Therapeutics Inc

ALRN
1,75
-0,01 (-0,57%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:15PRNUSAileron Therapeutics Reports Third Quarter 2024 Financial..
14/11/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202413:00PRNUSAileron Therapeutics Announces Positive Topline Data from..
31/10/202412:30PRNUSAileron Therapeutics and Advancium Health Network Announce..
12/10/202415:00PRNUSAileron Therapeutics to Present Previously Announced Data..
23/9/202413:30PRNUSAileron Therapeutics Completes Enrollment in Cohort 2 of the..
22/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:17EDGAR2Form 8-K - Current report
19/8/202422:05PRNUSAileron Therapeutics to Present at the 8th Annual IPF Summit
15/8/202400:05PRNUSAileron Therapeutics Reports Second Quarter 2024 Financial..
14/8/202423:23EDGAR2Form 8-K - Current report
14/8/202423:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202414:00PRNUSAileron Therapeutics to Present at the Canaccord Genuity..
26/7/202422:36EDGAR2Form 8-K - Current report
26/7/202422:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202422:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/7/202414:41EDGAR2Form ARS - Annual Report to Security Holders
09/7/202414:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/7/202414:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/7/202414:00PRNUSAileron Therapeutics to be Included in the Russell Microcap®..
05/6/202412:58EDGAR2Form 8-K - Current report
16/5/202423:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/5/202423:01EDGAR2Form 8-K - Current report
15/5/202423:16EDGAR2Form 8-K - Current report
15/5/202423:13GLOBEAileron Therapeutics Reports First Quarter 2024 Financial..
15/5/202423:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05GLOBEAileron Therapeutics to Present at Two Upcoming Investor..
03/5/202422:05GLOBEAileron Therapeutics Announces Closing of Underwritten..
01/5/202414:45GLOBEAileron Therapeutics Announces Pricing of Underwritten..
01/5/202414:30GLOBEAileron Therapeutics Announces Positive Data from Cohort 1..
15/4/202423:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12/3/202413:00GLOBEAileron Therapeutics Announces CEO Transition
06/3/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:01EDGAR2Form 8-K - Current report
15/2/202422:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13/2/202413:01EDGAR2Form 8-K - Current report
05/2/202419:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
31/1/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202422:10EDGAR2Form S-3 - Registration statement under Securities Act of..
29/1/202414:46EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202414:14EDGAR2Form 8-K - Current report
Apertura: 1,75 Min: 1,70 Max: 1,88
Chiusura: 1,76

La tua Cronologia

NASDAQ
ALRN
Aileron Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network